OOIR: Observatory of International Research

Papers

(The TQCC of Mycoses is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Author Index	62
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	52
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	52
	48
Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021	46
Physicians' knowledge of invasive fungal disease in China	46
T Cell Exhaustion and Function State Correlated With Outcomes in Patients With Intra‐Abdominal Candidiasis	37
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	36
Issue Information	35
Issue Information	34
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	34
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	33
Review Article White Piedra: Review of 131 cases	31
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	28
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	27
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	26
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	26
Emergence of Candida auris in intensive care units in Algeria	25
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	24
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	24
The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice	24
Issue Information	22
Issue Information	22
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	21
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	21

Cover Image	20
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	20
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	20
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	20
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	19
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	19
Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive Aspergillosis	19
Utility and Pitfalls of β‐D‐Glucan for Diagnosis and Response Monitoring of Chronic Disseminated Candidiasis in Paediatric Cancer Patients	19
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	18
	18
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	18
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	18
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	18
Issue Information	18
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	17
Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review	17
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	17
Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.	17
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	16
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	16
Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Tri	16
Optimisation of a Murine Infection Model With Trichophyton mentagrophytes for Studying the Pathogenesis of Dermatophytosis	16
	16
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	16
Tinea pedis in underrepresented groups: All of Us database analysis	15
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	15
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	15
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	15
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	15
Diagnostic performance of noncultural methods for central nervous system aspergillosis	15
CARD9 mutations in patients with fungal infections: An update from the last 5 years	15
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	14
	14
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	14
	14
	14
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	14
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	13
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	13
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	13
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	13
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	13
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	13
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	13
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	12
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	12
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	12
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	12
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	12
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	12

Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	12
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	11
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	11
Epidemiology and Pathogen Shift of Tinea Capitis: A Comparative Analysis of Adults and Children in Nanchang, China (2022–2024)	11
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	11
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	11
	11
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	11
	11
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	10
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	10
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	10
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	10
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	10
Epidemiology of Triazole Resistant Aspergillus fumigatus in Asia: A Systematic Review and Meta‐Analysis	10
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	10
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	10
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	10
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	10
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	10
	10
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	10
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	10
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	9
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	9
Aspergillus nodules: Natural history and the effect of antifungals	9
Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation In	9
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	9
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	9
Issue Information	9
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species‐Specific IgG	9
Expert recommendations for prevention and management of Candida auris transmission	9
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	9
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	9
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	9
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	9
	9
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	8
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	8
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	8
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	8
Updated estimation of the burden of fungal disease in Vietnam	8
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	8
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	8
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	8
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	8
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China	8
Usefulness of ¹⁸F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	7
Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
The First Isolation of Multiple Antifungal‐Drug‐Resistant Trichophyton Rubrum in China and the Novel Resistance Mechanism	7
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
Issue Information	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	7
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	7
Abstracts	7
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Issue Information	7
Time and cost‐efficient identification of Trichophyton indotineae	7